semaglutide memory loss Weight Drug Shows Promise as Alzheimer's Treatment : ScienceAlert Semaglutide in early-stage Alzheimer's Disease

This includes the first oral GLP-1s approved for weight loss (Wegovy pill, Foundayo) and GLP-1 injections (Wegovy, Zepbound, Ozempic)

As a result, semaglutide was FDA-approved in 2021 for weight loss as Wegovy

Generally, the GLP-1RAs also lower blood pressure

3.2 In vivo evidence Liu et al

The Y-maze test, implemented on Day 21, measured exploratory activity, behavior, and recognition memory

The decrease in S100a8, S100a9, and Cxcl2 levels suppress inflammation and oxidative stress in cardiac muscle, thereby reducing the risk of myocardial infarction, heart failure, arteriosclerosis, and myocardial reperfusion injury